Jacques Borg was born in Strasbourg (France) in 1951. He received the M.D. and Ph.D. degree (neurochemistry) from Université Louis Pasteur, Strasbourg, France, in 1978 and 1984, respectively. In 1981, he was Assistant Professor at Faculty of Medecine, Université Louis Pasteur, Strasbourg, France. From 1987 to 1989, he was Visiting Professor at University of California, Irvine, Irvine, Calif, USA. He was a Visiting Professor at the Institute for Research in Biomedicine, Barcelona, Spain (2008–2009). Since 2002, he is Professor of biochemistry at the Faculty of Medecine, Jean Monnet University, Saint Etienne, France. Borg was the founder of two biotech start-up companies, Medafor and Neurofit in 1989 and 1996, respectively. He heads the scientific board of AFRT, dedicated to research on Down syndrome. He is mainly interested in studying neuronal survival and the role of trophic factors or free radicals during various neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). Studies are performed with neuronal cultures or animal models for ALS, with biochemical assays, MRI, or behavioral tests. On the clinical side, he is searching for biomarkers in cerebrospinal fluid during degenerative dementias or ALS, through quantitative proteomic analysis. He is involved in various networks joining neurologists and specialists in neurochemistry or mass spectrometry. Borg is inventor in various patents related to the nonproteic trophic factor, n-hexacosanol, or biomarkers for diagnosis of ALS. He is member of various task force groups related to clinical chemistry development in diagnosis of neurodegenerative diseases.
Biography Updated on 14 January 2011